CTSO - Wutah pendapatan taun lumaku Cytosorbents

The scaling of robotic assembly lines and the implementation of AI-driven control are driving momentum, which is confirmed by the current trailing 12-month sales growth rate year-over-year, where 9.10 represents the latest metric reading for Cytosorbents (CTSO). The business relies on the sale of blood purification systems and high-margin consumables. The market capture strategy is based on the expansion of CytoSorb cartridges into cardiac surgery centers.
CytoSorbents Corp (CTSO) - rincian metrik lan laporan keuangan

This indicator measures revenue dynamics over a rolling 12-month period, neutralizing seasonality and quarterly gaps. Analyzing this trend allows investors to promptly identify slowing demand or an expansion phase. This daily price chart of revenue growth over the last 12 months YoY makes it easy to determine the fundamental stability of the business. For Cytosorbents (CTSO), this reflects the adoption rate of adsorbers in intensive care practice. The growth of this metric confirms the expanding presence of blood purification technologies within the hospital sector.